Everence Capital Management Inc. cut its position in Owens & Minor, Inc. (NYSE:OMI – Free Report) by 15.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,110 shares of the company’s stock after selling 1,900 shares during the period. Everence Capital Management Inc.’s holdings in Owens & Minor were worth $132,000 as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in the company. Deerfield Management Company L.P. Series C boosted its holdings in shares of Owens & Minor by 30.6% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 6,371,440 shares of the company’s stock worth $86,014,000 after acquiring an additional 1,493,852 shares in the last quarter. Foundry Partners LLC bought a new stake in shares of Owens & Minor during the third quarter worth $5,238,000. Charles Schwab Investment Management Inc. increased its stake in shares of Owens & Minor by 10.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,028,236 shares of the company’s stock valued at $31,823,000 after buying an additional 187,079 shares in the last quarter. Algert Global LLC raised its holdings in shares of Owens & Minor by 189.4% in the third quarter. Algert Global LLC now owns 276,438 shares of the company’s stock valued at $4,337,000 after buying an additional 180,922 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its position in Owens & Minor by 16.5% during the 2nd quarter. Renaissance Technologies LLC now owns 1,246,600 shares of the company’s stock worth $16,829,000 after buying an additional 176,250 shares in the last quarter. 98.04% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
OMI has been the subject of several research reports. Robert W. Baird lowered their price objective on shares of Owens & Minor from $19.00 to $14.00 and set a “neutral” rating for the company in a research report on Tuesday, November 5th. Barclays dropped their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 5th. UBS Group decreased their price objective on Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Finally, Citigroup dropped their target price on Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $18.50.
Insider Activity
In other news, CFO Jonathan A. Leon sold 5,282 shares of the business’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $11.82, for a total transaction of $62,433.24. Following the completion of the sale, the chief financial officer now owns 130,822 shares in the company, valued at $1,546,316.04. The trade was a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 3.59% of the company’s stock.
Owens & Minor Stock Performance
Shares of NYSE:OMI opened at $14.38 on Friday. The firm’s 50 day simple moving average is $13.17 and its 200 day simple moving average is $14.21. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. Owens & Minor, Inc. has a fifty-two week low of $11.42 and a fifty-two week high of $28.35. The company has a market capitalization of $1.11 billion, a price-to-earnings ratio of -22.12, a P/E/G ratio of 0.48 and a beta of 0.46.
Owens & Minor (NYSE:OMI – Get Free Report) last released its earnings results on Monday, November 4th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.01. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The business had revenue of $2.72 billion for the quarter, compared to the consensus estimate of $2.68 billion. During the same quarter in the previous year, the business earned $0.44 earnings per share. Owens & Minor’s quarterly revenue was up 5.0% on a year-over-year basis. As a group, sell-side analysts forecast that Owens & Minor, Inc. will post 1.49 earnings per share for the current year.
Owens & Minor Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Further Reading
- Five stocks we like better than Owens & Minor
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Best Stocks Under $10.00
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- The Risks of Owning Bonds
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Want to see what other hedge funds are holding OMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Owens & Minor, Inc. (NYSE:OMI – Free Report).
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.